Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 02 - 25 tags : Covid save search
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®
Published: 2021-02-25 (Crawled : 21:00) - biospace.com/
CODX | $1.17 1.74% 1.71% 33K
|
Health Technology
|
| O: -2.04%
H: 4.16%
C: -5.75%
covid saliva test diagnostic
Independent Data Monitoring Committee Finds Clear Efficacy for REGEN-COV™ (casirivimab with imdevimab) in Phase 3 COVID-19 Outpatient Outcomes Trial
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.37%
H: 1.02%
C: -1.55%
covid phase 3 trial casirivimab
DTRA Awards Leidos Project to Conduct Clinical Trials for COVID-19 Therapeutics
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
LDOS | $128.9 0.17% 0.0% 830K
|
Technology Services
|
| O: -0.42%
H: 0.28%
C: -0.97%
covid trial covid-19 awards
Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19
Published: 2021-02-25 (Crawled : 14:05) - globenewswire.com
ATOS | $1.505 1.01% 1.0% 1.9M
|
Health Technology
|
| O: 19.78%
H: 0.9%
C: -12.61%
covid phase 1 results phase 3 phase 2
O2TODAY and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19
Published: 2021-02-25 (Crawled : 14:04) - globenewswire.com
SINT | $0.0385 7.54% 7.01% 45M
|
Health Technology
|
| O: 8.33%
H: 19.43%
C: -2.02%
covid commercialization covid-19
Altimmune Commences Enrollment in Phase 1 Clinical Trial of AdCOVID™ -- a Needle-Free, Single-Dose Intranasal COVID-19 Vaccine Candidate
Published: 2021-02-25 (Crawled : 12:05) - globenewswire.com
ALT | $7.095 -6.28% -6.69% 2.2M
|
Commercial Services
|
| O: -3.93%
H: 4.68%
C: -8.56%
covid adcovid phase 1 vaccine trial phase 3 phase 2 enroll
Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT
Published: 2021-02-25 (Crawled : 12:03) - globenewswire.com
CMRX | $0.9033 -2.38% -2.44% 88K
|
Health Technology
|
| O: 0.69%
H: 6.44%
C: 4.1%
covid results trial topline covid-19
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
Published: 2021-02-25 (Crawled : 12:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.21%
H: 0.86%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.61%
H: 2.16%
C: -2.21%
covid new vaccine vaccine
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.